| PMSF |
drug |
4 |
1 |
phenylmethylsulfonyl fluoride |
| PNC |
gene |
2 |
1 |
Philadelphia Neurodevelopmental Cohort |
| PNOC |
gene |
4 |
4 |
N/OFQ precursor, Nociceptin, nociceptin/orphanin FQ, prepronociceptin, preproorphanin |
| Poisson distribution |
drug |
2 |
1 |
|
| Poland |
cohort |
3 |
1 |
|
| polyA tail |
drug |
2 |
1 |
|
| polybrene |
drug |
4 |
1 |
|
| poly-D-lysine |
drug |
8 |
2 |
PDL |
| polyethylenimine |
drug |
5 |
2 |
PEI |
| PolyFun |
drug |
2 |
2 |
PolyFun30 |
| polygenic influences |
cohort |
2 |
2 |
|
| polygenic risk score |
cohort |
43 |
36 |
GPS, GRS, PGS, PGSs, PRS, PS, Tourette PRS, adjusted PRS, common-variant PRS, genetic risk scores, highest PRS decile, neuropsychiatric PRS, polygenic risk, polygenic risk estimates, polygenic risk score, polygenic risk scores, polygenic score, polygenic scores, polygenic sum scores, raw PRS, trans-ancestry PRS |
| Polygenic risk score for alcohol dependence |
phenotype |
10 |
8 |
PGRS, PRS, PRS for alcohol dependence, alcohol dependence polygenic risk, alcohol problems polygenic score, genome-wide polygenic score for alcohol problems, high PRS, higher genetic risk for alcoholism, lower genetic risk for alcoholism, polygenic risk, polygenic risk score |
| poly-l-ornithine |
drug |
6 |
2 |
PLL, PLO, poly-L-ornithine (Sigma #P4957) |
| Polymorphism |
cohort |
6 |
2 |
genetic variants, polymorphism, polymorphisms, specific polymorphism |
| poly-ornithine |
drug |
4 |
1 |
|
| polyornithine |
drug |
2 |
2 |
poly-L-ornithine, polyornithine (0.1mg/mL) |
| Polyphen2 |
drug |
8 |
1 |
PolyPhen-2, PolyPhen2 [HDIV], Polyphen2 HDIV |
| polysubstance abuse |
phenotype |
11 |
8 |
polysubstance abuse, polysubstance use, use more than one substance |
| polysubstance dependence |
phenotype |
6 |
3 |
SUDcombined, polysubstance dependence, severity of polysubstance dependence |
